Bridging the innovation gap for neglected tropical diseases in México: capacity building for the development of a new generation of antipoverty vaccines
Bol. méd. Hosp. Infant. Méx
;
68(2): 150-158, mar.-abr. 2011. ilus, tab
Article
in English
| LILACS
| ID: lil-700895
ABSTRACT
The neglected tropical diseases (NTDs) represent a group of chronic parasitic and related infections that promote poverty because of their impact on child development, pregnancy, and worker productivity. The estimated 20 million Mexicans who live below the poverty line suffer disproportionately from a high prevalence of neglected tropical diseases such as amebiasis, Chagas disease, dengue, leishmaniasis, soil-transmitted helminth infections, trachoma, and vivax malaria. However, because the NTDs occur predominantly among the poor, new industrial and financial models are required to establish innovative technologies to address these conditions in Mexico and elsewhere in Latin America. In response, the Slim Initiative for Antipoverty Vaccine Development was established to foster a public/private partnership between key academic, government, and industrial institutions in the U.S. and Mexico. Initial emphasis will be placed on developing new vaccines for Chagas disease and leishmaniasis, two of the highest burden NTDs in Mexico and Mesoamerica.
Full text:
Available
Index:
LILACS (Americas)
Type of study:
Risk factors
Country/Region as subject:
Mexico
Language:
English
Journal:
Bol. méd. Hosp. Infant. Méx
Journal subject:
Pediatrics
Year:
2011
Type:
Article
Affiliation country:
United States
Institution/Affiliation country:
George Washington University/US
Similar
MEDLINE
...
LILACS
LIS